Hetero

Hetero website: www.heterodrugs.com

🔎 Run a search for “Hetero”

Get RSS feed of these results

All stories

Story
9 October 2008

Major drug firms agree with Ban Ki-Moon to invest more in AIDS treatments & diagnostics for poor regions

See full story

Article
9 October 2008

Secretary-General's statement following meeting with pharmaceutical and diagnostic companies working on HIV and AIDS

Author: United Nations

I met today with senior executives of seventeen of the world's research-based and generic pharmaceutical and diagnostic companies…to review progress on...expand[ing] access to HIV prevention, treatment, care and support services in low- and middle...

Read more

Article
23 November 2007

The bold Thai health minister who rattled big pharma will step aside after next month’s election

Author: Daniel Ten Kate, Asia Sentinel [Hong Kong]

The bold Thai health minister who rattled big pharma will step aside after next month’s election…A year ago, Thailand sent shockwaves around the pharmaceutical world when it announced it would issue a compulsory license for the patented AIDS drug[s].....

Read more

Article
31 May 2007

Boehringer offers HIV drug without patents

Author: Bhuma Shrivastava, Mint [India]

...Boehringer Ingelheim has decided not to enforce patents on its anti-HIV drug, Nevirapine, in 78 low-income African and Asian countries...In a statement on its website, Boehringer says it will issue “short, non-assert declarations”, or licences, to...

Read more

Article
15 February 2007

It’s patent vs patient in AIDS fight [India]

Author: Noemie Bisserbe, Economic Times [India]

NGOs...are fighting pharma MNCs [multinationals] trying to patent their anti-AIDS drugs in India. So far, 12 anti-AIDS drugs for which patents are being sought by pharma MNCs [including GlaxoSmithKline, Boehringer Ingelheim, Gilead Sciences, Abbott...

Read more

Article
3 February 2007
+ Français - Hide

Author: Philippe Rivière, Le Monde Diplomatique

le 30 janvier, le ministre de la santé, M. Mongkol na Songkla, a signé le décret qui lui permet de prendre des licences obligatoires sur le Kaletra (un traitement anti-VIH) du laboratoire américain Abbot et le Plavix, un anticoagulant du laboratoire...

Read more

Article
24 August 2006

After Glaxo patent, it is Novartis' turn [India]

Author: Amrita Nair-Ghaswalla, Times of India

The success of activists in forcing GlaxoSmithKline to withdraw the patent application for its HIV/AIDS drug combivir in India is now spurring on others. Cancer patients and non-government organisations have decided to rally against Swiss...

Read more

Article
25 July 2006

Annan pushes AIDS drug makers to lower prices

Author: Irwin Arieff, Reuters

U.N. Secretary-General Kofi Annan encouraged executives from nine drug companies on Monday to lower prices of AIDS medicines and step up efforts to develop AIDS drugs and diagnostics for children... At his request, the officials agreed to review the...

Read more

Article
24 July 2006

"AIDS pandemic is still outpacing our efforts", broad partnership needed to step up response,says Secretary-General after meeting with pharmaceutical executives

Author: United Nations

Following is UN Secretary-General Kofi Annan’s statement, issued following a meeting with top pharmaceutical executives on HIV/AIDS, in New York, 24 July:....In the five years since I first met with pharmaceutical company executives, we have seen...

Read more

Story
24 July 2006

Kofi Annan pushes AIDS drug makers on prices, drugs & diagnostics for children - 9 major firms agree to review prices of medicines & diagnostics, develop paediatric formulations

See full story